We are proud to announce that LUX DS and the Centre for Clinical Innovations of the University of
Dundee have been jointly awarded a grant by the Technology Strategy Board (TSB) for the
development of a novel photonics-based medical device for the assessment of dental disease. LUX
DS was selected among over one hundred companies that submitted proposals for the
"Technologies for Health" competition, organised by the TSB in order to improve healthcare
provision. The twenty???two finalists, including LUX DS, will share approximately 10 million pounds for the
development of new technologies that will help to bring healthcare closer to the community.
LUX has been able to apply its substantial expertise with light???based technologies to the dental field
and in collaboration with the University of Dundee we are developing Carivis™, a clinical device that
will allow dentists to easily and accurately visualise active tooth decay. Although tooth decay (or
dental caries) is largely preventable, it nonetheless remains one of the most prevalent diseases.
Fortunately, decay ???if caught early enough??? can be arrested and even reversed by improving oral
hygiene and through dentist???applied preventive treatments such as varnishes, sealants, etc. The key
to doing this successfully is to identify active decay earlier, more accurately and in hard to access
surfaces such as between the teeth and in fissures. Carivis™ addresses these difficulties and is an
innovative approach to assess the activity of caries lesions in one visit to the dental practice, as well
as assist in monitoring the ongoing effect of preventive measures to arrest the activity of these
lesions.
The revolutionary Carivis™ caries assessment system is based on Glowdent™, a compound which
emits light in the presence of active tooth decay. Along with its continuing partnership with the
Centre for Clinical Innovations of the University of Dundee, LUX DS is working across the dental
industry to apply the extraordinary abilities of Glowdent™ from the clinic and dental research lab to
the home diagnostics market. We have a particular interest in applications within the field of dental
erosion (tooth wear), which is an increasing problem in the western world, especially among
children.
"This award is a direct recognition of the groundbreaking work that we are conducting towards the
development of novel tools in preventive dentistry" said LUX Innovate Ltd CEO, Dr Artin Moussavi.
"Tooth decay still affects more than 80% of the population and current detection technologies are
designed for locating cavities that require fillings. On the other hand, the Carivis™ system for
assessment of caries activity focuses on managing the disease by giving dental practitioners the
unprecedented ability to look into its early stages and offer preventive solutions to the patient. The
funding received from the TSB is expected to significantly accelerate progress towards the regulatory
approval of Carivis™, allowing us to bring its benefits to the dental chair".
About the Technology Strategy Board
The TSB is an executive non???departmental public body established in 2007, with a focus in boosting
UK growth and productivity, by stimulating technology???enabled innovation. Its activities are jointly
supported and funded by the Department for Innovation, Universities and Skills and other
Government Departments, the Devolved Administrations, Regional Development Agencies and
Research Councils.
About LUX DS
LUX DS specialises in the development of novel applications in the field of dentistry and oral health
and is the dental division of LUX Innovate Ltd., a technology development house with a focus on
deploying its core expertise in light???based technologies, to develop and commercialise novel
detection solutions across different industries.
LUX has a strong, comprehensive in???house research team and the company is geared towards
efficient co???development of novel light based technological solutions. With a track record of working
successfully with major players, LUX has fulfilled unmet needs in a number of industries. The
company has ongoing co???development projects in the energy, chemical, water quality, medical and
life science sectors with potential application development in many more.
LUX manages its diverse projects through three different divisions dedicated to the biotechnology
(LUX Biotechnology), energy and chemical (LUX Assure) and medical (LUX DS) sectors.
LUX Innovate Ltd was established in 2001 in Edinburgh, UK. It is a privately owned and funded
company, led by a robust and experienced management team. LUX has won many awards for
innovation and has partnered with a number of companies and research groups worldwide.
About the Centre for Clinical Innovations (CCI) at the University of Dundee
CCI is a 'half way house' ??? where University research meets commercial priorities for new knowledge,
which can then be applied profitably and practically to enhance health and health care.
Established in 2001, Directed by Professor Pitts with Dr Longbottom as Associate Director, CCI is
linked to the University's Research & Innovations Services Office and has working relationships in the
College of Medicine, Dentistry & Nursing, within the University.
CCI's research focuses on: a) Identification of novel and effective solutions to improve both oral
health and health care, b) High quality research and development appropriate to modern health
care and c) Effective dissemination and commercial exploitation of findings.
The Centre has excellent working relationships with a number of multi???national players in the oral
health/healthcare Industries, as well as with smaller companies and with collaborators in other
Universities.
Source
Centre for Clinical Innovations (CCI) at the University of Dundee
Комментариев нет:
Отправить комментарий